Cha Biotech announced on January 14 that it has decided to conduct a third-party allotment capital increase to raise approximately 10 billion won in operating funds.
A total of 771,664 new common shares will be issued at 12,959 won per share. The third-party allotment recipient is LG CNS Co., Ltd.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
